InsidersTradesSigma
BioGaia AB Stock: price and management transactions · Finland · FIN-FSA
Follow the BioGaia AB stock price and the full directors' dealings record of the company, a publicly traded company based in Finland. Shares trade on FI FI, under the supervision of FIN-FSA. Operating in the Health Care sector, BioGaia AB has recorded 6 public disclosures. Market capitalisation: €13.2bn. The latest transaction was disclosed on 13 August 2025 (Purchase). Among the most active insiders: Theresa Puleo Agnew. All data is accessible without an account.
6
Insider Decl.
0
Thresholds
€34,674
4 ops.
Buy Volume
€17m
2 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate BioGaia AB Strong Buy (bullish), based on 1 analysts. Average price target: SEK 165.00.
35Σ signal
Fundamental score
Ranked 6,314 of 25,899 companies
64.4
score / 100
Value39
Quality90
FCF yld2.5%
Earn yld2.8%
EV/EBITDA26.5x
ROE21%
Gross mgn73%
Net mgn22%
Debt/EBITDA0.0x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 13 August 2025
Declarations6 total
1,767 shares@ €8.4450.0001% mcap100.0% of flowAktieFI:A003R373-1
Ideal exit: 8 May 2026 (T+270)
1,038,202 shares@ €11.89130.094% mcap100.0% of flowAktieFI:A003O682-1
136 shares@ €9.82280.0000% mcap6.8% of flowAktieFI:A003O451-1
Ideal exit: 10 Feb 2026 (T+270)
500,000 shares@ €9.87960.038% mcap100.0% of flowAktieFI:A003O299-1
2,015 shares@ €9.13930.0001% mcap93.2% of flowAktieFI:A003O021-1
Ideal exit: 2 Feb 2026 (T+270)
60,000 shares0OptionFI:A003M373-1
Ideal exit: 5 Dec 2025 (T+270)
6 of 6 declarations